Second Sight Medical Products Inc. (NASDAQ: EYES) started the day on April 30, 2021, with a price decrease of -3.77% at $6.89. During the day, the stock rose to $7.1391 and sunk to $6.76 before settling in for the price of $7.16 at the close. Taking a more long-term approach, EYES posted a 52-week range of $0.69-$20.00.
Meanwhile, its Annual Earning per share during the time was 30.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 68.30%. This publicly-traded company’s shares outstanding now amounts to $23.16 million, simultaneously with a float of $13.25 million. The organization now has a market capitalization sitting at $199.81 million. At the time of writing, stock’s 50-day Moving Average stood at $7.99, while the 200-day Moving Average is $2.95.
Second Sight Medical Products Inc. (EYES) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Second Sight Medical Products Inc.’s current insider ownership accounts for 35.63%, in contrast to 2.50% institutional ownership.
Second Sight Medical Products Inc. (EYES) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 6/29/2020, the organization reported -$0.15 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.41) by $0.26. This company achieved a return on equity of -450.70. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Second Sight Medical Products Inc.’s EPS increase for this current 12-month fiscal period is 68.30%.
Second Sight Medical Products Inc. (NASDAQ: EYES) Trading Performance Indicators
Let’s observe the current performance indicators for Second Sight Medical Products Inc. (EYES). It’s Quick Ratio in the last reported quarter now stands at 0.80. The Stock has managed to achieve an average true range (ATR) of 0.89.
In the same vein, EYES’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.84.
Technical Analysis of Second Sight Medical Products Inc. (EYES)
If we take a close look at the recent performances of Second Sight Medical Products Inc. (NASDAQ: EYES), its last 5-days Average volume was 1.04 million that shows plunge from its year to date volume of 19.19 million. During the previous 9 days, stock’s Stochastic %D was recorded 25.27% While, its Average True Range was 0.77.
Raw Stochastic average of Second Sight Medical Products Inc. (EYES) in the period of the previous 100 days is set at 29.67%, which indicates a major rise in contrast to 6.53% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 55.84% that was lower than 312.97% volatility it exhibited in the past 100-days period.